Asset Allocation

As of September 30, 2025.
Type % Net
Cash 10.99%
Stock 52.40%
Bond 24.96%
Convertible 0.00%
Preferred 0.00%
Other 11.65%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.63%    % Emerging Markets: 0.66%    % Unidentified Markets: 11.71%

Americas 73.40%
72.74%
Canada 55.27%
United States 17.47%
0.66%
Mexico 0.60%
As of September 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 8.84%
United Kingdom 2.72%
6.12%
France 1.29%
Germany 0.28%
Ireland 0.14%
Italy 1.67%
Netherlands 0.64%
Spain 1.62%
Switzerland 0.49%
0.00%
0.00%
Greater Asia 6.05%
Japan 0.48%
5.48%
Australia 5.48%
0.09%
Taiwan 0.09%
0.00%
Unidentified Region 11.71%

Bond Credit Quality Exposure

AAA 50.51%
AA -1.63%
A 20.94%
BBB 20.91%
BB 3.61%
B 0.61%
Below B 0.37%
    CCC 0.37%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.15%
Not Available 4.52%
Short Term 0.00%
As of September 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
47.54%
Materials
22.08%
Consumer Discretionary
0.72%
Financials
0.07%
Real Estate
24.67%
Sensitive
24.16%
Communication Services
0.27%
Energy
14.67%
Industrials
8.92%
Information Technology
0.29%
Defensive
16.82%
Consumer Staples
0.07%
Health Care
2.71%
Utilities
14.03%
Not Classified
11.48%
Non Classified Equity
0.86%
Not Classified - Non Equity
10.62%
As of September 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2025
Type % Net
Government 51.73%
Corporate 45.48%
Securitized 0.00%
Municipal 0.00%
Other 2.79%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.44%
Less than 1 Year
0.44%
Intermediate
79.31%
1 to 3 Years
42.22%
3 to 5 Years
20.69%
5 to 10 Years
16.40%
Long Term
20.25%
10 to 20 Years
1.59%
20 to 30 Years
18.27%
Over 30 Years
0.40%
Other
0.00%
As of September 30, 2025
View Bond Maturity Exposure
Start Trial